Tools
Crouzon Syndrome
Introduction
Crouzon syndrome is a genetically inherited disorder characterized by multiple suture craniosynostosis (premature fusion of the coronal sutures), leading to skull and facial deformities. This condition was first described in 1912 by French physician Octave Crouzon, who identified both a mother and daughter with what was originally termed "craniofacial dysostosis."[1] He described a triad of skull deformities, facial anomalies, and proptosis, which was later relabeled as "Crouzon syndrome" (see Image. Crouzon Syndrome in a Patient Exhibiting Craniofacial Deformities).
Crouzon syndrome is a congenital disorder inherited in an autosomal dominant pattern. This syndromic condition exhibits complete penetrance but variable expressivity, meaning symptom severity varies among individuals.[2] Craniosynostosis is the distinguishing feature of Crouzon syndrome, which typically affects the coronal sutures, although other sutures may also be involved. Premature suture closure disrupts the balance between intracranial pressure and cranial vault development, leading to compensatory growth of unaffected sutures. This results in a brachycephalic cranium shape, midface hypoplasia, shallow orbits, and maxillary hypoplasia.[3]
The underdevelopment of the maxilla and zygomatic arches causes midface hypoplasia, a defining characteristic of Crouzon syndrome.[4] This anomaly leads to aesthetic concerns and contributes to functional impairments, such as malocclusion and upper airway obstruction.[5] Proptosis, hypertelorism, and vision impairment result from orbital dysmorphology, which leads to exposure keratopathy and optic atrophy.[6]
Progressive craniofacial dysmorphism and complications, including developmental delays, obstructive sleep apnea, and elevated intracranial pressure, are characteristic of untreated Crouzon syndrome.[7] Early surgical interventions are essential to manage the condition, enhance quality of life, and prevent complications.[8] A multidisciplinary approach involving physicians, geneticists, ophthalmologists, neurosurgeons, and plastic craniofacial surgeons is crucial to addressing the diverse clinical manifestations.[9] The diagnosis of Crouzon syndrome is predominantly clinical, with genetic testing and radiological imaging providing additional support.
Etiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
Crouzon syndrome follows an autosomal dominant inheritance pattern and results from mutations in the fibroblast growth factor receptor (FGFR2 and FGFR3) genes on chromosome 10.[10][11] The syndrome exhibits complete penetrance with variable expressivity, leading to a wide range of phenotypic severity within the same family, from mild features to severe deformities. Approximately 50% of cases result from de novo mutations.[12] The FGFR2 gene encodes a transmembrane receptor essential for cell signaling during bone formation and development.[13] Mutations cause a gain-of-function effect, leading to hyperactive FGFR2 signaling and the premature differentiation and fusion of cranial sutures.[14]
Although FGFR2 mutations are the most commonly implicated, mutations in the FGFR3 and TWIST1 genes have been associated with rare cases of Crouzon syndrome.[15] Approximately 50% of sporadic cases result from de novo mutations, while the remaining cases are inherited in an autosomal dominant pattern.[16] FGFR2 mutations can be transmitted through parental mosaicism despite its rarity. An increased likelihood of de novo FGFR2 mutations has been associated with advanced paternal age, potentially due to replication errors during spermatogenesis. The FGFR2 receptor is involved in several signaling pathways, including the MAPK/ERK pathway, which regulates the proliferation and differentiation of osteoblasts.[17]
Hyperactive signaling accelerates suture ossification, disrupting the normal development of the cranium. Although the coronal sutures are most commonly affected, the involvement of the sagittal and lambdoid sutures can contribute to diverse craniofacial phenotypes.[18] These mutations impair the normal function of receptors and disrupt downstream signaling pathways. Genetic testing for specific mutations is crucial to confirm the diagnosis and guide genetic counseling. While environmental factors do not directly influence the etiology of Crouzon syndrome, adverse craniofacial development has been associated with maternal conditions such as gestational diabetes.
Epidemiology
Crouzon syndrome is a rare condition, occurring in approximately 1 in 60,000 newborns. This condition is the second most common craniosynostosis syndrome, following the more recently described Muenke syndrome.[19][20] The worldwide incidence of Crouzon Syndrome is estimated at 1.6 per 100,000 individuals, accounting for 4.5% of all craniosynostosis cases.[21] Although no significant gender predilection has been reported, racial and ethnic disparities in incidence rates may exist due to variations in genetic backgrounds and differences in healthcare access.
Despite the potential for underdiagnosis in resource-limited settings, incidence rates remain consistent globally. The sporadic nature of the condition is highlighted by the fact that de novo mutations account for 50% to 60% of cases.[16] The age of diagnosis is contingent upon the severity of craniofacial abnormalities. Imaging and physical examination are commonly used to identify severe cases during pregnancy or at birth. Milder cases may remain undiagnosed until later in childhood when developmental delays or functional impairments become apparent. No gender bias has been observed. However, there is ongoing interest in studying the environmental and genetic factors that influence FGFR2 mutations.[22]
The natural history of Crouzon syndrome is characterized by progressive craniofacial dysmorphism, with significant variability in phenotypic expression. Some individuals present with isolated craniosynostosis, whereas others experience extensive multisystem involvement, including hydrocephalus, airway obstruction, and hearing loss.[23] These distinctions emphasize the significance of individualized patient assessment and management.[24]
Pathophysiology
Mutations in the FGFR2 gene, which encodes a transmembrane receptor responsible for regulating osteoblast differentiation and proliferation, can cause Crouzon syndrome. FGFR2 is critical in maintaining the balance between osteoblast proliferation and differentiation in the cranial sutures. When this balance is disrupted by hyperactivation of FGFR2, it leads to premature suture fusion, also known as craniosynostosis. The FGFR family comprises 4 genes (FGFR1, FGFR2, FGFR3, and FGFR4), with FGFR2 being the most closely associated with cranial development. FGFR2 and FGFR3 are 2 of the 4 transmembrane protein receptors responsible for osteoblast differentiation during embryological development.
FGFR2 mutations in Crouzon syndrome result in gain-of-function alterations, leading to the premature ossification of cranial sutures, which is a defining feature of the condition. Cranial sutures facilitate the expansion of the cranium and the growth of the brain during embryogenesis.[25] Missense mutations in FGFR2 and FGFR3 receptors accelerate osteoblast differentiation.[26] A detailed discussion of these receptors and their downstream signaling can be found in Azoury et al.[27] This process results in the premature fusion of sutures, although the reasons behind the involvement of specific sutures remain unclear.
Depending on the sutures involved, different abnormal skull growth patterns can occur. The coronal sutures are the most frequently affected in Crouzon syndrome, although other sutures may also fuse prematurely, leading to variable cranial morphologies such as brachycephaly, scaphocephaly, or trigonocephaly. Brachycephaly, characterized by a widened and shortened skull, is the most common presentation due to bi-coronal suture fusion. However, trigonocephaly (triangular-shaped skull) and scaphocephaly (long and narrow skull) are also observed. In the most severe cases, the closure of multiple sutures results in a "cloverleaf" skull, also known as Kleeblattschadel deformity. Please see StatPearls' companion resource, "Craniosynostosis," for more information.
The compensatory overgrowth at uninvolved sutures results from the premature fusion of cranial sutures, contributing to the distinctive craniofacial characteristics of Crouzon syndrome.[28] Proptosis, hypertelorism, and exposure keratopathy occur as a result of abnormal growth patterns in the anterior cranial base, leading to shallow orbits.[29] Furthermore, midface hypoplasia is commonly associated with malocclusion and airway obstruction due to the underdevelopment of the zygomatic complex and maxilla.[30] Other prevalent findings include hydrocephalus, which is a result of impaired cerebrospinal fluid drainage, and elevated intracranial pressure, which, if left untreated, can result in cognitive delays.[31] Both structural factors, such as maxillary hypoplasia, and functional factors, such as nasopharyngeal airway restriction, contribute to the pathogenesis of airway obstruction in Crouzon syndrome. Over time, these complications can worsen due to the progressive deformities seen in untreated cases.
Histopathology
The aberrant development and ossification of cranial sutures are key features of Crouzon syndrome's histopathology. Increased osteoblastic activity and fibrosis at the fused sutures are associated with premature closure and disorganized bony architecture.[32] Histological analysis reveals irregular osteoid deposition, hyperplastic periosteum, and abnormal collagen matrix formation in the affected sutures. The fibrocellular layer, which is crucial for maintaining suture patency during cranial growth, is notably reduced in the abruptly fused sutures when observed under microscopy.
Thickening and increased mineralization are observed in the bone structures that underlie the affected area.[33] Furthermore, osteoblast hyperactivity induced by dysregulated FGFR2 signaling accelerates suture ossification. A significant finding in Crouzon syndrome is the presence of aberrant endochondral ossification in regions typically designated for intramembranous ossification.
This histological hallmark further underscores the critical role of FGFR2 in cranial suture biology. In cases of midface hypoplasia, the cortical bone layer becomes thinner, and the trabecular bone volume in the maxillary bones is reduced. Abnormalities in soft tissue, such as thickened periosteum and altered vascular patterns, are also observed, particularly around the fused sutures. These modifications can lead to impaired cranial remodeling and persistent deformities, even after surgical correction. Understanding these histopathological characteristics is essential for developing therapeutic strategies that are specifically tailored to the individual patient's needs.[34]
History and Physical
Understanding family history is essential due to the autosomal dominant inheritance pattern of Crouzon syndrome.[35] The clinical course of progressive facial deformities during the first 1 to 2 years of life is key to making the clinical diagnosis, and additional testing is often unnecessary to make the clinical diagnosis. As a genetic disorder, the remainder of the newborn's history is unlikely to provide further insight into the underlying diagnosis. The clinical manifestation of Crouzon syndrome is highly variable, reflecting its complete penetrance and variable expressivity.
Crouzon syndrome is usually suspected at birth due to characteristic facial and cranial deformities, along with a positive family history. Several characteristic features of Crouzon syndrome are often evident upon physical examination. The most common include brachycephaly, wide-set eyes (hypertelorism), bulging eyes (proptosis), a flattened forehead, a "parrot-beak" nose, and underdevelopment of the upper jaw (maxillary/midface hypoplasia), which together define the Crouzonoid face.[36] These patients may also experience cleft lip and/or palate and dental issues.
Neurological findings can include developmental delays or signs of elevated intracranial pressure, such as papilledema, vertigo, or irritability. In severe cases, imaging may reveal hydrocephalus. Additional systemic findings may involve visual impairments, such as exposure keratopathy or optic atrophy. The incidence of strabismus (misaligned eyes) is notably high.[37] Hearing loss can arise as a result of eustachian tube dysfunction and conductive hearing loss.
Comprehensive documentation of these characteristics is essential for facilitating diagnostic evaluations and treatment planning. An important distinction is the normal appearance of the hands and feet in Crouzon syndrome, in contrast to the pronounced syndactyly seen in Apert syndrome,[38] which is a similar but more severe craniosynostosis disorder, which presents with pronounced syndactyly of the extremities. Additionally, Pfeiffer syndrome,[39] another form of craniosynostosis, is characterized by short, broad big toes and thumbs, in contrast to the normal digits found in individuals with Crouzon syndrome.[19] Please see StatPearls' companion resource, "Pfeiffer Syndrome," for more information.
Evaluation
The evaluation for Crouzon syndrome is relatively straightforward when there is a known family history, as characteristic physical findings typically confirm the diagnosis. However, in cases involving a spontaneous mutation or an unclear clinical presentation, genetic testing for FGFR2 mutations may be necessary for diagnosis.[40] Additional tests in these situations may include imaging techniques such as magnetic resonance imaging (MRI) and computed tomographic (CT) imaging of the brain, which can detect craniosynostosis or other skeletal abnormalities.[41]
The most common imaging findings on x-ray–based techniques include perisutural sclerosis, reduced serration, bony bridging, and/or the absence of the suture altogether.[42] A "beaten bronze" appearance of the skull is also frequently observed on CT scans due to multiple radiolucencies in the skull bones. MRI is particularly advantageous for evaluating intracranial structures and identifying complications, including hydrocephalus and Chiari anomalies.[43] These imaging modalities also aid in detecting sequelae of the syndrome, including radiographic signs of increased intracranial pressure, which may be difficult to detect in uncooperative children.[44]
If the history records, physical examination, and findings from imaging tests remain inconclusive, molecular testing may be considered. However, as multiple craniosynostosis syndromes involve defects in FGFR genes, there can be significant overlap in their molecular pathophysiology.[27] For patients with a family history of Crouzon syndrome (or other craniosynostosis syndromes), prenatal genetic testing, along with 2-dimensional (2D) and 3D ultrasounds, can help confirm the diagnosis before the birth of the child.[27] In high-risk pregnancies, amniocentesis or chorionic villus sampling may be performed. However, it is essential to thoroughly discuss the associated risks and benefits with the parents before proceeding.
A vision examination is crucial for detecting optic atrophy, amblyopia, or exposure keratopathy.[45] Optical coherence tomography, fluorescein angiography, and ocular echography may be considered for patients with severe orbital deformities presenting with vision loss and visual field defects. Audiometry is used to evaluate conductive or sensorineural hearing loss.[46] Polysomnography may be recommended in cases of suspected obstructive sleep apnea.[47] Early multidisciplinary evaluation is crucial for optimizing outcomes and preventing complications in these patients. While not all assessments are necessary for every case, a thorough family history, characteristic physical examination findings, advanced imaging modalities, and genetic testing aid in distinguishing Crouzon syndrome from other craniosynostosis syndromes, such as Pfeiffer, Apert, Saethre-Chotzen, Carpenter, and Jackson-Weiss syndromes, which share overlapping clinical features.[48]
Treatment / Management
The treatment of patients with Crouzon syndrome and other craniosynostosis conditions is highly complex, requiring a multidisciplinary team to address various functional and aesthetic concerns. Key specialists include pediatricians, oral and maxillofacial surgeons, plastic surgeons, neurosurgeons, otorhinolaryngologists (ENT), and ophthalmologists (pediatric and oculoplastics). Additional specialists may be necessary for the management of Crouzon syndrome, depending on the patient's specific complications.
A combination of surgical, medical, and supportive interventions is essential to addressing functional impairments and improving the quality of life for patients with Crouzon syndrome. Surgery is the primary treatment modality to correct midface and orbital maldevelopment, thereby preventing blindness and intellectual disability caused by restricted brain and orbital growth. A comprehensive review of surgical techniques, including optimal timing for repair, is available in recent literature.[49]
Most craniofacial surgeons agree that single-suture craniosynostosis can usually be corrected with a single surgery, whereas multiple-suture craniosynostosis often requires a staged approach aligned with facial growth patterns. In cases involving extensive bony loss and fragmentation across the orbitomaxillary region, bone grafting should be considered to restore the lost bony architecture, followed by distraction osteogenesis to advance the midface. Bone grafting can be performed before initiating distraction to enhance structural stability and optimize outcomes.
Gradual advancement using distraction osteogenesis offers a greater chance of achieving significant midface advancement in a stable manner. Successful application of this technique requires a complete and continuous skeletal structure. A more conservative approach allows bone grafts to heal before proceeding with distraction in a delayed setting. Open vault treatments, such as strabismus surgery, can be considered before other surgical corrections. When cranial vault abnormalities are corrected, patients with Crouzon syndrome can experience normal cognitive function, vision, hearing, and lifespan.
Fortunately, not all patients will require surgery, thereby making a team-based approach essential for monitoring the development of complications related to the syndrome that may require intervention. The overall prognosis depends on the severity of the malformations and the timing of their correction. Early correction, ideally before age 1, has been anecdotally shown to minimize cognitive disabilities, airway obstructions, and decreased visual acuity, leading to better outcomes.[50] Long-term follow-up is required to monitor ocular development, as patients with Crouzon syndrome are prone to develop strabismic amblyopia and may require strabismus surgery. Regular examinations should also assess for optic nerve edema, which could indicate elevated intracranial pressure. Additionally, due to changes in the airway, sleep apnea is a concern.(B3)
A collaborative approach involving neurologists, ophthalmologists, orthodontists, geneticists, and craniofacial surgeons is necessary to provide comprehensive care. Ongoing monitoring of developmental progress and prompt management of emerging complications require consistent long-term follow-up. Ongoing research is investigating the role of tyrosine kinase inhibitors in craniosynostosis conditions associated with mutated FGFR.[51] However, these studies have not yet been tested in humans and are likely several years away from clinical application.[14][52]
Differential Diagnosis
A comprehensive evaluation of Crouzon syndrome is crucial to exclude other diagnoses, as it shares overlapping features with several other craniosynostosis syndromes and conditions. The timing of surgery and the need for genetic counseling depend on the underlying diagnosis, making accurate differentiation vital for appropriate management.
The differential diagnoses include:
- Apert syndrome: A craniosynostosis syndrome associated with FGFR2 mutations, it is one of the primary differentials. Similar to Crouzon syndrome, Apert syndrome features multiple suture craniosynostosis and midface hypoplasia. However, it is distinguished by syndactyly (fusion of digits and toes) and more severe cognitive impairment in the majority of cases. Specific FGFR2 mutations associated with Apert syndrome can be identified through genetic testing.[53]
- Pfeiffer syndrome: Similar to Crouzon syndrome, Pfeiffer syndrome is characterized by multiple suture craniosynostosis and midfacial retrusion. However, it is distinguished by broad, medially deviated fingertips and digits. Furthermore, while a cloverleaf cranium deformity is uncommon in Crouzon syndrome, it is seen in severe cases of Pfeiffer syndrome (type II or III).[54]
- Saethre-Chotzen syndrome: This condition is most commonly caused by mutations in the TWIST1 gene and is characterized by craniosynostosis, facial asymmetry, and ptosis. Unlike Crouzon syndrome, Saethre-Chotzen syndrome typically involves fewer sutures and presents with a milder phenotype.[55]
- Non-syndromic craniosynostosis: This condition is characterized by the isolated fusion of sutures without any associated systemic findings. The absence of characteristic facial features or genetic mutations, along with a thorough clinical history and physical examination, helps exclude this condition.[56]
- Treacher Collins syndrome: Patients with this condition exhibit midfacial hypoplasia but lack craniosynostosis.[57]
- Goldenhar syndrome: This condition is characterized by facial asymmetry and auricular abnormalities, which are the 2 additional conditions that can resemble certain features of Crouzon syndrome.[58]
- Rare syndromes such as Carpenter syndrome and Muenke syndrome: To differentiate Crouzon syndrome from Carpenter syndrome [59] and Muenke syndrome,[60] a combination of genetic testing, imaging, and clinical assessment is essential for an accurate diagnosis. This approach ensures that treatment plans and prognostic expectations are tailored accordingly.
Staging
Although Crouzon syndrome lacks a formal staging system such as those used in malignancies or other progressive diseases, its severity and phenotypic spectrum can be classified based on the extent of craniosynostosis, midface hypoplasia, and associated functional impairments. These clinical stages can influence the timing and strategies for interventions. Patients may exhibit isolated coronal synostosis and minimal midface hypoplasia in moderate cases. These patients often have relatively normal intracranial pressure and airway patency, requiring fewer surgical interventions. Moderate cases are characterized by more pronounced midface hypoplasia, often accompanied by proptosis, malocclusion, and sleep-disordered breathing. Severe cases typically involve multiple suture craniosynostosis, significant proptosis, and complications such as hydrocephalus, optic atrophy, or airway obstruction.
An additional beneficial framework involves evaluating the progression of complications. This stratified approach enables clinicians to prioritize interventions, such as midface advancement or cranial vault remodeling, based on the patient's most urgent needs, which include:
- Cranial involvement: The extent of intracranial pressure and suture fusion.[61]
- Ophthalmologic impact: The severity of proptosis, exposure keratopathy, and optic neuropathy.[62]
- Midfacial abnormalities: The extent of hypoplasia and its effect on airway function and nutrition.[63]
- Neurological and developmental status: The presence of hydrocephalus, increased intracranial pressure, or cognitive delays.[64]
Prognosis
The prognosis for patients with Crouzon syndrome relies on early diagnosis and timely treatment. When addressed promptly, patients may experience a near-normal lifespan. The prognosis of Crouzon syndrome is influenced by the severity of craniosynostosis and the presence of associated complications. Although some challenges may persist, most patients can achieve a satisfactory quality of life through early surgical intervention and a multidisciplinary approach. When craniosynostosis is addressed promptly, patients with moderate phenotypes often experience near-normal life expectancy and developmental outcomes. However, untreated cases can lead to severe complications, such as cognitive impairment, hydrocephalus, and vision loss due to optic nerve compression.[65]
If left untreated, proptosis and midface hypoplasia can lead to chronic exposure keratopathy, recurrent infections, and airway obstruction. Surgical interventions, such as cranial vault remodeling and LeFort III osteotomy, significantly improve functional outcomes in these patients.[66] A LeFort III advancement involves shifting the entire midface forward. Additional surgeries may be needed during growth phases due to the continuous development of the skeleton. Neurological outcomes depend on the management of hydrocephalus and intracranial pressure.[67] In most cases, cognitive delays are mild but can be severe if complications arise early in life. Timely interventions require ongoing developmental assessments.
Complications
Crouzon syndrome is associated with various complications affecting different organ systems, including:
- Elevated intracranial pressure: This is one of the most significant complications resulting from premature suture closure. In severe instances, elevated intracranial pressure can lead to cognitive impairment, papilledema, and migraines.[68]
- Visual complications: These include proptosis, which increases the risk of corneal ulceration and exposure keratopathy. A more severe complication is optic atrophy, which can lead to irreversible vision loss and may result from elevated intracranial pressure or direct optic nerve compression.[69]
- Airway complications: Midface hypoplasia and narrowed nasal passages are common causes of airway issues. These can lead to obstructive sleep apnea, chronic hypoxia, and feeding difficulties. Severe cases may present with aspiration pneumonia, breathing difficulties, and stridor.[70]
- Hearing loss: Eustachian tube dysfunction and structural abnormalities of the middle ear are the main contributors to conductive hearing loss in Crouzon syndrome.[71]
- Dental abnormalities: Malocclusion, congestion, and a high-arched palate are common in these patients, complicating speech development and feeding.[72]
- Other systemic complications: These include hydrocephalus and Chiari malformations, which may develop and require neurosurgical interventions.[73]
Consultations
A multidisciplinary team is essential for the comprehensive management of Crouzon syndrome, and key specialists involved in patient care include:
- Pediatricians
- Ophthalmologists (pediatric and oculoplastics)
- Maxillofacial surgeons
- Neurosurgeons
- Plastic surgeons
- Otorhinolaryngology specialists
Deterrence and Patient Education
The parents of the patient should be counseled about the child's condition and the expected prognosis. Genetic evaluation should be offered to them as part of comprehensive patient education. Educating families is essential for helping them identify potential complications at an early stage and obtain prompt treatment. Genetic counseling is indispensable for families contemplating future pregnancies, as Crouzon syndrome is likely to recur in affected parents. Counseling should also include information on the sporadic nature of de novo mutations.
Parents should be instructed on how to identify signs of elevated intracranial pressure, such as persistent migraines, regurgitation, or developmental regression, as these require immediate medical attention. Caregivers should also be aware of ocular symptoms, including excessive tearing or inflammation, which may indicate exposure keratopathy.
Pearls and Other Issues
Early diagnosis and surgical intervention significantly improve both functional and cosmetic outcomes in Crouzon syndrome. Comprehensive care involves a multidisciplinary team, including surgeons, neurologists, and geneticists. Genetic testing facilitates the assessment of recurrence risk and provides a definitive diagnosis. Proactive management of vision and airway complications prevents long-term morbidity.
Enhancing Healthcare Team Outcomes
The treatment of patients with Crouzon syndrome and other craniosynostosis conditions is complex and challenging. To effectively address the diverse needs of these patients, it is essential to establish a multidisciplinary healthcare team. This interprofessional healthcare team should include pediatricians, oral maxillofacial surgeons, plastic surgeons, craniofacial surgeons, neurosurgeons, otorhinolaryngologists (ENT specialists), orthodontists, speech therapists, geneticists, and ophthalmologists (pediatric and oculoplastics). Nurses involved in care must be specially trained to identify complications and educate families.
An interprofessional approach fosters the best patient outcomes. Transparent communication and collaborative decision-making are key to enhancing care. Early surgical intervention, guided by radiological findings and clinical assessments, helps prevent complications. Long-term follow-up and careful management ensure timely detection of emergent complications and allow for adjustments to treatment plans as the infant develops.
Media
(Click Image to Enlarge)
Crouzon Syndrome in a Patient Exhibiting Craniofacial Deformities.
Octave Crouzon, Public Domain, via Wikimedia Commons
References
Kaushik A, Bhatia H, Sharma N. Crouzon's Syndrome: A Rare Genetic Disorder. International journal of clinical pediatric dentistry. 2016 Oct-Dec:9(4):384-387. doi: 10.5005/jp-journals-10005-1395. Epub 2016 Dec 5 [PubMed PMID: 28127173]
Paradowska-Stolarz AM, Ziomek M, Sluzalec-Wieckiewicz K, Duś-Ilnicka I. Most common congenital syndromes with facial asymmetry: A narrative review. Dental and medical problems. 2024 Nov-Dec:61(6):925-932. doi: 10.17219/dmp/186086. Epub [PubMed PMID: 39496100]
Level 3 (low-level) evidenceAlam MK, Alfawzan AA, Abutayyem H, Kanwal B, Alswairki HJ, Verma S, Ganji KK, Munisekhar MS, Siddiqui AA, Fahim A. Craniofacial characteristics in Crouzon's syndrome: A systematic review and meta-analysis. Science progress. 2023 Jan-Mar:106(1):368504231156297. doi: 10.1177/00368504231156297. Epub [PubMed PMID: 36803068]
Level 1 (high-level) evidencePellerin P, Vinchon M, Guerreschi P, Anastassov Y, Zhang ZY, Tang XJ, Alonso N. Crouzon Syndrome Anatomy, Usefulness of Vestibular Orientation. The Journal of craniofacial surgery. 2022 Sep 1:33(6):1914-1923. doi: 10.1097/SCS.0000000000008644. Epub 2022 Mar 14 [PubMed PMID: 35288499]
Gupta R, Debnath N, Rawat P, Singh N. Crouzon's syndrome and its dentofacial features. BMJ case reports. 2023 Nov 23:16(11):. doi: 10.1136/bcr-2023-258125. Epub 2023 Nov 23 [PubMed PMID: 37996136]
Level 3 (low-level) evidenceGuarnizo Capera AP, Campaña Perilla LA, Rueda MA, Cardona Ortegón JD, Triana Rodriguez GA. Crouzon syndrome with kleeblattschädel skull. Acta neurologica Belgica. 2024 Jun:124(3):1011-1012. doi: 10.1007/s13760-023-02178-1. Epub 2023 Jan 31 [PubMed PMID: 36720799]
Lu X, Forte AJ, Junn A, Dinis J, Alperovich M, Alonso N, Persing JA. Orbitofacial morphology changes with different suture synostoses in Crouzon syndrome. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery. 2022 May:50(5):406-418. doi: 10.1016/j.jcms.2021.06.012. Epub 2021 Jun 23 [PubMed PMID: 35065874]
Harmon KA, Ferraro J, Rezania N, Carmona T, Figueroa AA, Tragos C. Crouzon Syndrome Spanning Three Generations: Advances in the Treatment of Syndromic Midface Deficiency. Plastic and reconstructive surgery. Global open. 2023 Nov:11(11):e5296. doi: 10.1097/GOX.0000000000005296. Epub 2023 Nov 28 [PubMed PMID: 38033876]
Level 3 (low-level) evidenceSawh-Martinez R, Steinbacher DM. Syndromic Craniosynostosis. Clinics in plastic surgery. 2019 Apr:46(2):141-155. doi: 10.1016/j.cps.2018.11.009. Epub [PubMed PMID: 30851747]
Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature genetics. 1994 Sep:8(1):98-103 [PubMed PMID: 7987400]
Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nature genetics. 1995 Dec:11(4):462-4 [PubMed PMID: 7493034]
Pal US, Gupta C, Chellappa AA. Crouzon syndrome with primary optic nerve atrophy and normal brain functions: A case report. Journal of oral biology and craniofacial research. 2012 May-Aug:2(2):116-8. doi: 10.1016/j.jobcr.2012.03.011. Epub 2012 Jun 27 [PubMed PMID: 25737846]
Level 3 (low-level) evidenceFan J, Li Y, Jia R, Fan X. An inherited FGFR2 mutation increased osteogenesis gene expression and result in Crouzon syndrome. BMC medical genetics. 2018 May 30:19(1):91. doi: 10.1186/s12881-018-0607-8. Epub 2018 May 30 [PubMed PMID: 29848297]
Morice A, de La Seiglière A, Kany A, Khonsari RH, Bensidhoum M, Puig-Lombardi ME, Legeai Mallet L. FGFR antagonists restore defective mandibular bone repair in a mouse model of osteochondrodysplasia. Bone research. 2025 Jan 21:13(1):12. doi: 10.1038/s41413-024-00385-x. Epub 2025 Jan 21 [PubMed PMID: 39837840]
Yapijakis C, Pachis N, Sotiriadou T, Vaila C, Michopoulou V, Vassiliou S. Molecular Mechanisms Involved in Craniosynostosis. In vivo (Athens, Greece). 2023 Jan-Feb:37(1):36-46. doi: 10.21873/invivo.13052. Epub [PubMed PMID: 36593018]
Luong ALT, Ho TT, Hoang H, Nguyen TQ, Ho TC, Tran PD, Hoang TT, Nguyen NT, Chu HH. Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome. Biomedical reports. 2019 Feb:10(2):107-112. doi: 10.3892/br.2019.1181. Epub 2019 Jan 3 [PubMed PMID: 30719288]
Lee KKL, Peskett E, Quinn CM, Aiello R, Adeeva L, Moulding DA, Stanier P, Pauws E. Overexpression of Fgfr2c causes craniofacial bone hypoplasia and ameliorates craniosynostosis in the Crouzon mouse. Disease models & mechanisms. 2018 Nov 9:11(11):. doi: 10.1242/dmm.035311. Epub 2018 Nov 9 [PubMed PMID: 30266836]
Shakir S, Birgfeld CB. Syndromic Craniosynostosis: Cranial Vault Expansion in Infancy. Oral and maxillofacial surgery clinics of North America. 2022 Aug:34(3):443-458. doi: 10.1016/j.coms.2022.01.006. Epub 2022 Jul 2 [PubMed PMID: 35787825]
Mathijssen IM. Guideline for Care of Patients With the Diagnoses of Craniosynostosis: Working Group on Craniosynostosis. The Journal of craniofacial surgery. 2015 Sep:26(6):1735-807. doi: 10.1097/SCS.0000000000002016. Epub [PubMed PMID: 26355968]
Rannan-Eliya SV, Taylor IB, De Heer IM, Van Den Ouweland AM, Wall SA, Wilkie AO. Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis. Human genetics. 2004 Aug:115(3):200-7 [PubMed PMID: 15241680]
Dicus Brookes C, Golden BA, Turvey TA. Craniosynostosis syndromes. Atlas of the oral and maxillofacial surgery clinics of North America. 2014 Sep:22(2):103-10. doi: 10.1016/j.cxom.2014.04.001. Epub [PubMed PMID: 25171992]
Subbiah V, Sahai V, Maglic D, Bruderek K, Touré BB, Zhao S, Valverde R, O'Hearn PJ, Moustakas DT, Schönherr H, Gerami-Moayed N, Taylor AM, Hudson BM, Houde DJ, Pal D, Foster L, Gunaydin H, Ayaz P, Sharon DA, Goyal L, Schram AM, Kamath S, Sherwin CA, Schmidt-Kittler O, Jen KY, Ricard F, Wolf BB, Shaw DE, Bergstrom DA, Watters J, Casaletto JB. RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations. Cancer discovery. 2023 Sep 6:13(9):2012-2031. doi: 10.1158/2159-8290.CD-23-0475. Epub [PubMed PMID: 37270847]
Couloigner V, Ayari Khalfallah S. Craniosynostosis and ENT. Neuro-Chirurgie. 2019 Nov:65(5):318-321. doi: 10.1016/j.neuchi.2019.09.015. Epub 2019 Sep 27 [PubMed PMID: 31568777]
Lu X, Forte AJ, Park KE, Allam O, Smetona J, Alperovich M, Steinbacher DM, Tonello C, Alonso N, Persing JA. Airway Growth in Preoperative Patients with Crouzon Syndrome. Facial plastic surgery & aesthetic medicine. 2021 May-Jun:23(3):191-197. doi: 10.1089/fpsam.2020.0441. Epub 2021 Feb 12 [PubMed PMID: 33577380]
Di Rocco F, Biosse Duplan M, Heuzé Y, Kaci N, Komla-Ebri D, Munnich A, Mugniery E, Benoist-Lasselin C, Legeai-Mallet L. FGFR3 mutation causes abnormal membranous ossification in achondroplasia. Human molecular genetics. 2014 Jun 1:23(11):2914-25. doi: 10.1093/hmg/ddu004. Epub 2014 Jan 12 [PubMed PMID: 24419316]
Level 3 (low-level) evidenceSnyder-Warwick AK, Perlyn CA, Pan J, Yu K, Zhang L, Ornitz DM. Analysis of a gain-of-function FGFR2 Crouzon mutation provides evidence of loss of function activity in the etiology of cleft palate. Proceedings of the National Academy of Sciences of the United States of America. 2010 Feb 9:107(6):2515-20. doi: 10.1073/pnas.0913985107. Epub 2010 Feb 1 [PubMed PMID: 20133659]
Level 3 (low-level) evidenceAzoury SC, Reddy S, Shukla V, Deng CX. Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis. International journal of biological sciences. 2017:13(12):1479-1488. doi: 10.7150/ijbs.22373. Epub 2017 Nov 2 [PubMed PMID: 29230096]
Tonpe S, Warbhe H, Banode P, Kommuru S, Nagendra V. Radiological Diagnosis of Crouzon Syndrome: A Case Study. Cureus. 2024 Jun:16(6):e62564. doi: 10.7759/cureus.62564. Epub 2024 Jun 17 [PubMed PMID: 39027794]
Level 3 (low-level) evidenceRollon-Mayordomo A, Mataix-Albert B, Espejo-Arjona F, Herce-Lopez J, Lledo-Villar L, Caparros-Escudero C, Infante-Cossio P. Neurotrophic Keratitis in a Pediatric Patient With Goldenhar Syndrome and Trigeminal Aplasia Successfully Treated by Corneal Neurotization. Ophthalmic plastic and reconstructive surgery. 2022 Mar-Apr 01:38(2):e49-e51. doi: 10.1097/IOP.0000000000002086. Epub [PubMed PMID: 34798657]
De Stefano S, Nadal López E, Sabas M. Simultaneous Lefort 2 Distraction and Fronto-Orbito-Malar Advancement: Correcting Severe Upper and Midface Retrusion in a Patient With Crouzon Syndrome. The Journal of craniofacial surgery. 2024 Dec 30:():. doi: 10.1097/SCS.0000000000010956. Epub 2024 Dec 30 [PubMed PMID: 39787498]
Kilcoyne S, Scully P, Overton S, Brockbank S, Thomas GPL, Ching RC, Jayamohan J, Ramsden JD, Jones J, Wilkie AOM, Johnson D. Speech and Language Development, Hearing, and Feeding in Patients With Genetically Confirmed Crouzon Syndrome With Acanthosis Nigricans: A 36-Year Longitudinal Retrospective Review of Patients at the Oxford Craniofacial Unit. The Journal of craniofacial surgery. 2024 Mar 20:():. doi: 10.1097/SCS.0000000000010085. Epub 2024 Mar 20 [PubMed PMID: 38506523]
Level 2 (mid-level) evidenceWang Y, Liu Y, Chen H, Liu X, Zhang Y, Wang Y, Gu Y. FGFR2 Mutation p.Cys342Arg Enhances Mitochondrial Metabolism-Mediated Osteogenesis via FGF/FGFR-AMPK-Erk1/2 Axis in Crouzon Syndrome. Cells. 2022 Oct 5:11(19):. doi: 10.3390/cells11193129. Epub 2022 Oct 5 [PubMed PMID: 36231091]
Ajami S, Van den Dam Z, Hut J, Savery D, Chin M, Koudstaal M, Steacy M, Carriero A, Pitsillides A, Chang YM, Rau C, Marathe S, Dunaway D, Jeelani NUO, Schievano S, Pauws E, Borghi A. Cranial bone microarchitecture in a mouse model for syndromic craniosynostosis. Journal of anatomy. 2024 Dec:245(6):864-873. doi: 10.1111/joa.14121. Epub 2024 Aug 2 [PubMed PMID: 39096036]
Fujii Y, Okabe I, Hatori A, Sah SK, Kanaujiya J, Fisher M, Norris R, Terasaki M, Reichenberger EJ, Chen IP. Skeletal abnormalities caused by a Connexin43(R239Q) mutation in a mouse model for autosomal recessive craniometaphyseal dysplasia. Bone research. 2025 Jan 23:13(1):14. doi: 10.1038/s41413-024-00383-z. Epub 2025 Jan 23 [PubMed PMID: 39848944]
Deng M, Shen F, Yang Y. [Advances in genetic research on Non-syndromic congenital joint synostosis]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics. 2024 Aug 10:41(8):1001-1009. doi: 10.3760/cma.j.cn511374-20230729-00025. Epub [PubMed PMID: 39097287]
Level 3 (low-level) evidenceHennocq Q, Paternoster G, Collet C, Amiel J, Bongibault T, Bouygues T, Cormier-Daire V, Douillet M, Dunaway DJ, Jeelani NO, van de Lande LS, Lyonnet S, Ong J, Picard A, Rickart AJ, Rio M, Schievano S, Arnaud E, Garcelon N, Khonsari RH. AI-based diagnosis and phenotype - Genotype correlations in syndromic craniosynostoses. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery. 2024 Oct:52(10):1172-1187. doi: 10.1016/j.jcms.2024.02.010. Epub 2024 Feb 5 [PubMed PMID: 39187417]
Lee TC, Walker E, Ting MA, Bolar DS, Koning J, Korn BS, Kikkawa DO, Granet D, Robbins SL, Alperin M, Engle EC, Liu CY, Rudell JC. The influence of orbital architecture on strabismus in craniosynostosis. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024 Feb:28(1):103812. doi: 10.1016/j.jaapos.2023.10.006. Epub 2024 Jan 13 [PubMed PMID: 38219920]
Raposo-Amaral CE, Vincenzi-Lemes M, Medeiros ML, Raposo-Amaral CA, Ghizoni E. Apert syndrome: neurosurgical outcomes and complications following posterior vault distraction osteogenesis. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2024 Aug:40(8):2557-2563. doi: 10.1007/s00381-024-06436-2. Epub 2024 May 3 [PubMed PMID: 38700706]
Manji KP, Massomo MM, Akyoo ES, Luvinga MA. Type II Pfieffer misdiagnosed as Crouzon syndrome with additional features of supernumerary teeth and localized symmetrical gigantism: a case report. Journal of medical case reports. 2022 Nov 1:16(1):399. doi: 10.1186/s13256-022-03586-2. Epub 2022 Nov 1 [PubMed PMID: 36316724]
Level 3 (low-level) evidenceShi H, Yang J, Guo Q, Zhang M. Clinical assessment and FGFR2 mutation analysis in a Chinese family with Crouzon syndrome: A case report. Medicine. 2021 Mar 12:100(10):e24991. doi: 10.1097/MD.0000000000024991. Epub [PubMed PMID: 33725872]
Level 3 (low-level) evidenceLow XZ, Lim MC, Nga V, Sundar G, Tan AP. Clinical application of "black bone" imaging in paediatric craniofacial disorders. The British journal of radiology. 2021 Aug 1:94(1124):20200061. doi: 10.1259/bjr.20200061. Epub 2021 Jul 8 [PubMed PMID: 34233472]
Kim HJ, Roh HG, Lee IW. Craniosynostosis : Updates in Radiologic Diagnosis. Journal of Korean Neurosurgical Society. 2016 May:59(3):219-26. doi: 10.3340/jkns.2016.59.3.219. Epub 2016 May 10 [PubMed PMID: 27226852]
Bonsignore R, Ottenhausen M, Othman AE. [Acquired form of Chiari 1.5 malformation in Crouzon syndrome (dysostosis craniofacialis)]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2023 Nov:195(11):1027-1028. doi: 10.1055/a-2088-9633. Epub 2023 Jun 22 [PubMed PMID: 37348532]
Bonfield CM, Shannon CN, Reeder RW, Browd S, Drake J, Hauptman JS, Kulkarni AV, Limbrick DD, McDonald PJ, Naftel R, Pollack IF, Riva-Cambrin J, Rozzelle C, Tamber MS, Whitehead WE, Kestle JRW, Wellons JC, Hydrocephalus Clinical Research Network (HCRN). Hydrocephalus treatment in patients with craniosynostosis: an analysis from the Hydrocephalus Clinical Research Network prospective registry. Neurosurgical focus. 2021 Apr:50(4):E11. doi: 10.3171/2021.1.FOCUS20979. Epub [PubMed PMID: 33794488]
Fearon JA, Barrientos S, Ditthakasem K, Herbert M. Optic Nerve Atrophy in Syndromic Craniosynostosis. Plastic and reconstructive surgery. 2022 Aug 1:150(2):381e-386e. doi: 10.1097/PRS.0000000000009367. Epub 2022 Jun 8 [PubMed PMID: 35671456]
Chen J, Li W, Wen LT, Yang C, Sun CH, Qiu JH, Zha DJ. [Crouzon syndrome with secretory otitis media: a case report and literature review]. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery. 2019 Sep:33(9):845-847. doi: 10.13201/j.issn.1001-1781.2019.09.011. Epub [PubMed PMID: 31446701]
Level 2 (mid-level) evidenceThuy PT, Van Giap V, Martin F. Bilevel positive airway pressure treatment of sleep apnea syndrome in a patient with Crouzon syndrome. Sleep & breathing = Schlaf & Atmung. 2024 Nov 30:29(1):34. doi: 10.1007/s11325-024-03165-3. Epub 2024 Nov 30 [PubMed PMID: 39614948]
Casteleyn T, Horn D, Henrich W, Verlohren S. Differential diagnosis of syndromic craniosynostosis: a case series. Archives of gynecology and obstetrics. 2022 Jul:306(1):49-57. doi: 10.1007/s00404-021-06263-9. Epub 2021 Oct 11 [PubMed PMID: 34633507]
Level 2 (mid-level) evidenceTaylor JA, Bartlett SP. What's New in Syndromic Craniosynostosis Surgery? Plastic and reconstructive surgery. 2017 Jul:140(1):82e-93e. doi: 10.1097/PRS.0000000000003524. Epub [PubMed PMID: 28654610]
Warren SM, Proctor MR, Bartlett SP, Blount JP, Buchman SR, Burnett W, Fearon JA, Keating R, Muraszko KM, Rogers GF, Rubin MS, McCarthy JG. Parameters of care for craniosynostosis: craniofacial and neurologic surgery perspectives. Plastic and reconstructive surgery. 2012 Mar:129(3):731-737. doi: 10.1097/PRS.0b013e3182412a50. Epub [PubMed PMID: 22373978]
Level 3 (low-level) evidenceCarter EP, Fearon AE, Grose RP. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction. Trends in cell biology. 2015 Apr:25(4):221-33. doi: 10.1016/j.tcb.2014.11.003. Epub 2014 Nov 29 [PubMed PMID: 25467007]
Perlyn CA, Morriss-Kay G, Darvann T, Tenenbaum M, Ornitz DM. A model for the pharmacological treatment of crouzon syndrome. Neurosurgery. 2006 Jul:59(1):210-5; discussion 210-5 [PubMed PMID: 16823318]
Wu M, Massenburg BB, Villavisanis DF, Ng JJ, Romeo DJ, Wagner CS, Bartlett SP, Swanson JW, Taylor JA. Long-term photogrammetric outcomes of midface advancement in Apert syndrome: are we nearing normal? Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2024 Dec:40(12):4023-4032. doi: 10.1007/s00381-024-06611-5. Epub 2024 Sep 13 [PubMed PMID: 39269462]
Tie HX, Li TG, Xu FR, Wu WR, Ma B. An early prenatal diagnosis of type III Pfeiffer syndrome: a case description. Quantitative imaging in medicine and surgery. 2024 Dec 5:14(12):9835-9840. doi: 10.21037/qims-24-440. Epub 2024 Jul 9 [PubMed PMID: 39698725]
Level 2 (mid-level) evidenceJoksic I, Toljic M, Maksimovic N, Perovic D, Damnjanovic T, Jurisic A. Prenatal diagnosis of chromothripsis causing complex chromosomal rearrangement involving chromosomes 5, 7 and 11 leading to TWIST1 deletion and Saethre-Chotzen syndrome. Taiwanese journal of obstetrics & gynecology. 2025 Jan:64(1):134-137. doi: 10.1016/j.tjog.2024.09.023. Epub [PubMed PMID: 39794020]
Yildizdal S, Kaplan GO, Akca B, Kucukguven A, Işikay I, Vargel I. Fronto-orbital advancement: Comparison of syndromic and nonsyndromic craniosynostosis patients. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery. 2025 Jan 22:():. pii: S1010-5182(25)00026-5. doi: 10.1016/j.jcms.2025.01.015. Epub 2025 Jan 22 [PubMed PMID: 39848875]
Nassar JY, Kefi F, Alhartani MM, Sultan AA, Al-Khatib T, Safdar OY. Treacher Collins syndrome: A comprehensive review on clinical features, diagnosis, and management. Journal of family medicine and primary care. 2024 Oct:13(10):4165-4172. doi: 10.4103/jfmpc.jfmpc_851_24. Epub 2024 Oct 18 [PubMed PMID: 39629436]
Bari A, Sushma N, Shaw E, Agarwal T, Dada T, Sharma N. Anterior segment dysgenesis in Goldenhar syndrome. Eye (London, England). 2025 Feb:39(Suppl 1):64-65. doi: 10.1038/s41433-024-03386-6. Epub 2024 Oct 29 [PubMed PMID: 39472499]
Chau YY, Liang H, Tung WL, Hor CHH, Aik WS. Structural basis for Rab23 activation and a loss-of-function mutation in Carpenter syndrome. The Journal of biological chemistry. 2025 Jan:301(1):108036. doi: 10.1016/j.jbc.2024.108036. Epub 2024 Nov 29 [PubMed PMID: 39615683]
Singh GD. Mechanisms of midfacial hypoplasia in Muenke syndrome remain elusive. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2024 Dec:40(12):3893-3894. doi: 10.1007/s00381-024-06609-z. Epub 2024 Sep 9 [PubMed PMID: 39251439]
As'adi K, Ahmadi S, Mirsalehi M. Surgical treatment of craniofacial cleft and orbital hypertelorism: a single-center cohort study. Neurosurgical focus. 2025 Jan 1:58(1):E4. doi: 10.3171/2024.10.FOCUS24573. Epub [PubMed PMID: 39742519]
Chang YH, Staffa SJ, Yavuz Saricay L, Zurakowski D, Gise R, Dagi LR. Sensitivity, Specificity, and Cutoff Identifying Optic Atrophy by Macular Ganglion Cell Layer Volume in Syndromic Craniosynostosis. Ophthalmology. 2024 Mar:131(3):341-348. doi: 10.1016/j.ophtha.2023.09.022. Epub 2023 Sep 22 [PubMed PMID: 37742723]
Rickart AJ, Foti S, van de Lande LS, Wagner C, Schievano S, Jeelani NUO, Clarkson MJ, Ong J, Swanson JW, Bartlett SP, Taylor JA, Dunaway DJ. Using A Disentangled Neural Network to Objectively Assess the Outcomes of Midfacial Surgery in Syndromic Craniosynostosis. Plastic and reconstructive surgery. 2024 Aug 20:():. doi: 10.1097/PRS.0000000000011686. Epub 2024 Aug 20 [PubMed PMID: 39212945]
Kobets AJ, Alavi SAN, Ahmad SJ, Castillo A, Young D, Minuti A, Altschul DJ, Zhu M, Abbott R. Volumetric segmentation in the context of posterior fossa-related pathologies: a systematic review. Neurosurgical review. 2024 Apr 19:47(1):170. doi: 10.1007/s10143-024-02366-4. Epub 2024 Apr 19 [PubMed PMID: 38637466]
Level 1 (high-level) evidenceKogane N, Hennocq Q, Collet C, Touzé R, Arnaud É, Paternoster G, Khonsari RH. Optic nerve elongation during fronto-facial surgery for Crouzon syndrome: 3D quantification and clinical implications. Journal of neurosurgery. Pediatrics. 2024 Oct 1:34(4):414-422. doi: 10.3171/2024.5.PEDS2483. Epub 2024 Aug 2 [PubMed PMID: 39094185]
Brown KW, Edwards SR, Hoppe IC. Perioperative Management of Obstructive Sleep Apnea in Patients With Syndromic Craniosynostosis Undergoing LeFort III Osteotomy With Distraction: A Case Series. Craniomaxillofacial trauma & reconstruction. 2023 Dec:16(4):301-305. doi: 10.1177/19433875221142676. Epub 2022 Nov 28 [PubMed PMID: 38047148]
Level 2 (mid-level) evidenceCuperus IE, Mulders JY, Dremmen MHG, de Planque CA, Mathijssen IMJ, Van Veelen MC. Anomalous venous collaterals in Apert and Crouzon syndromes and their relationship to ventricle size and increased intracranial pressure. Journal of neurosurgery. Pediatrics. 2024 Nov 1:35(1):28-37. doi: 10.3171/2024.8.PEDS24111. Epub 2024 Nov 1 [PubMed PMID: 39486065]
Hersh DS, Hughes CD. Syndromic Craniosynostosis: Unique Management Considerations. Neurosurgery clinics of North America. 2022 Jan:33(1):105-112. doi: 10.1016/j.nec.2021.09.008. Epub 2021 Oct 26 [PubMed PMID: 34801135]
Rufai SR, Thomas MG, Marmoy OR, Panteli V, Thompson DA, Bunce C, Henderson RH, Gore S, James G, Gottlob I, Dunaway DJ, Hayward R, Proudlock FA, Jeelani NUO, Bowman R. Optic Nerve Head Morphological Variation in Craniosynostosis: A Cohort Study. American journal of ophthalmology. 2025 Jan:269():136-146. doi: 10.1016/j.ajo.2024.08.021. Epub 2024 Aug 30 [PubMed PMID: 39209208]
Yu L, Zhao Y. Adenoidectomy in a child with Crouzon syndrome complicated with severe obstructive sleep apnea: Case report and review of literature. Medicine. 2024 Jun 7:103(23):e38534. doi: 10.1097/MD.0000000000038534. Epub [PubMed PMID: 38847734]
Level 3 (low-level) evidenceMileshina NA, Fedoseev VI, Kurbatova EV, Osipenkov SS, Dobryakova MM. [The cochlear implantation in patients with syndromic deafness. Clinical examples]. Vestnik otorinolaringologii. 2022:87(4):23-26. doi: 10.17116/otorino20228704123. Epub [PubMed PMID: 36107176]
Pinto RO, Tonello C, Peixoto AP, de Jesus AS, Dos Santos-Pinto A, Raveli DB. Three-Dimensional Evaluation of Dental Arches in Individuals with Syndromic Craniosynostosis. International journal of dentistry. 2023:2023():1043369. doi: 10.1155/2023/1043369. Epub 2023 Jan 7 [PubMed PMID: 36647423]
Lu X, Sawh-Martinez R, Forte AJ, Wu R, Cabrejo R, Wilson A, Steinbacher DM, Alperovich M, Alonso N, Persing JA. Classification of Subtypes of Crouzon Syndrome Based on the Type of Vault Suture Synostosis. The Journal of craniofacial surgery. 2020 May/Jun:31(3):678-684. doi: 10.1097/SCS.0000000000006173. Epub [PubMed PMID: 32068731]